Transarterial Chemoembolization Plus Camrelizumab and Rivoceranib versus Camrelizumab and Rivoceranib Alone for BCLC Stage C Hepatocellular Carcinoma by Zhou WJ, Huang JT, Lu X, Hu D, Hong X, Wang FA, Lv PH, Zhu XL

Subjects: Get full text

A case report of immunotherapy-related breast reactive capillary endothelial proliferation by Chen JIE, Jing YU, Ru-Meng LI, Jun GONG, Cong-Hua XIE

Subjects: Get full text

Cost-effectiveness of camrelizumab plus rivoceranib for advanced hepatocellular carcinoma in the context of regional disparities in China by Zhonghua Zhao, Xiongying Jiang, Shiping Wen, Yanzhang Hao

Subjects: Get full text

Camrelizumab, an Anti‐PD‐1 Monoclonal Antibody, Plus Carboplatin and Nab‐Paclitaxel as First‐Line Setting for Extensive‐Stage Small‐Cell Lung Cancer: A Phase 2 Trial and Biomarker... by Jia Yu, Deyu Cai, Sha Zhao, Lei Wang, Xinlong Zheng, Anwen Xiong, Qi Wang, Bin Chen, Menghang Yang, Wei Li, Yan Wang, Jiajia Yuan, Changhong Zhao, Wei Shi, Caicun Zhou, Luonan Chen, Tao Jiang, Xiaohui Chen, Shengxiang Ren

Subjects: Get full text

Efficacy and safety of camrelizumab for the treatment of cervical cancer: a systematic review and meta-analysis by Xiaodong Mi, Fei Tuo, Tong Lin

Subjects: “…camrelizumab…”
Get full text

Efficacy and Safety of Hepatic Artery Infusion Chemotherapy Combined with Donafenib and Camrelizumab in the Treatment of Patients with Unresectable Hepatocellular Carcinoma: A Retr... by Wu C, Fu Z, Pan L, Li J, Zhou Y, Sun R, Gou Y, Zhao Y, Wang Z, Qiu Y, Huang P

Subjects: Get full text

Long survival after neoadjuvant and adjuvant camrelizumab plus chemotherapy and surgery in a patient with hepatoid adenocarcinoma of the lung: A case report by Xuhua Huang, Linhai Zhu, Weifeng Pan, Jian Hu

Subjects: Get full text

Case Report: Camrelizumab plus gemcitabine followed by concurrent chemoradiation for HPV-positive and PD-L1-positive tonsillar squamous cell carcinoma by Xuesong Li, Bianhong Wang, Hao Liu, Zhuo Yu

Subjects: Get full text

Efficacy and safety of camrelizumab plus Lacticaseibacillus paracasei in the treatment of advanced esophageal squamous cell carcinoma: A single-arm, single-center, exploratory tria... by Tengfei Zhang, Kang Cui, Xiaodan Liu, Yikai Han, Lin Li, Jinhui Xie, Xiangwen Dong, Yuhan Bao, Shengju Ren, Ziwen Lei, Pu Yu, Huan Zhao, Yabing Du, Wang Ma

Subjects: “…Camrelizumab…”
Get full text

Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for patients with unresectable hepatocellular carcinoma: a cost–utility analysis in China and the United States... by Qiuling Zhao, Yimin He, Zilin Nian, Yongjian Huang, Ruyi Huang, Lijun Lai, Lin Yang

Subjects: Get full text

Corrigendum: Case report: Long remission and survival following immunotherapy in a case of pulmonary pleomorphic carcinoma by Tongshan Wang, Muyang Chen, Anpeng Wang, Hao Zhang

Subjects: Get full text

Induction chemotherapy plus camrelizumab combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma in non-endemic areas: a phase 2 clinical tri... by Zhongqiu Wang, Yao Sun, Qingxin Wang, Yanlan Chai, Jian Sun, Ximei Zhang, Qi Wang, Wei Wang, Peiguo Wang

Subjects: “…Camrelizumab…”
Get full text

Hepatic Arterial Infusion Chemotherapy Combined Apatinib/Camrelizumab for Recurrent Hepatocellular Carcinoma After Hepatectomy by Zheng X, Qian K

Subjects: Get full text

The safety and effectiveness of sintilimab versus camrelizumab, both plus targeted drugs, in advanced hepatocellular carcinoma by Chenglong Zhao, Qiongni Zhu, Xiaoyan Qian, Zhonghua Fu, Wei Zhang, Yaqin Wang

Subjects: Get full text

Use of camrelizumab in treatment of nasopharyngeal carcinoma by Yu. V. Alymov, A. M. Mudunov, I. S. Romanov, B. G. Pkheshkhova

Subjects: Get full text

Camrelizumab in combination with doxorubicin, cisplatin, ifosfamide, and methotrexate in neoadjuvant treatment of resectable osteosarcoma: A prospective, single‐arm, exploratory ph... by Qinglian Tang, Xinke Zhang, Xiaojun Zhu, Huaiyuan Xu, Guohui Song, Jinchang Lu, Hao Wu, Chuangzhong Deng, Fei Ai, Yingchun Zhang, Jin Wang

Subjects: “…camrelizumab…”
Get full text

Overcoming therapeutic resistance in driver-negative NSCLC: Immunomodulatory mechanisms and clinical efficacy of Camrelizumab-chemotherapy combination in a real-world cohort by Yan Ge, Yang Zhao

Subjects: Get full text

Real-World Efficacy and Safety of Anti-PD-1 Antibody Plus Apatinib and Temozolomide for Advanced Acral Melanoma by Zhang J, Tian H, Mao L, Li C, Wei X, Gu J, Wang X, Zhou L, Lian B, Tang B, Yan X, Li S, Cui C, Chi Z, Sheng X, Guo J, Si L

Subjects: Get full text

A case of camrelizumab-induced anaphylaxis and successful rechallenge: a case report and literature review by Ping Song, Yuqi Jin, Yuqi Jin, Yuqi Jin, Lifang Dai, Lijun Fang, Yinuo Tan, Yinuo Tan, Yinuo Tan

Subjects: Get full text

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy for locally advanced rectal cancer: 3-year survival from a phase 2 study by Zhenyu Lin, Peng Zhang, Ming Cai, Gang Li, Tao Liu, Kailin Cai, Jing Wang, Junli Liu, Hongli Liu, Weikang Zhang, Jinbo Gao, Chuanqing Wu, Linfang Wang, Zheng Wang, Zhiguo Hou, Hongyi Kou, Kaixiong Tao, Tao Zhang

Subjects: Get full text